ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Ophthalmology

Top Ophthalmology Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RAYMOND FONG M.D.

Ophthalmology

22,367

$2.68M

3729
3435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

89%
prescriptions for brand name drugs

Avg: 63%

$120
Average prescription price

Avg: $88

SHELDON RABIN M.D.

Ophthalmology

13,425

$1.44M

1572
1328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 63%

$107
Average prescription price

Avg: $88

ILONA GENIS MD

Ophthalmology

12,636

$1.41M

1209
1168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

85%
prescriptions for brand name drugs

Avg: 63%

$112
Average prescription price

Avg: $88

JEFFREY SCHULTZ MD

Ophthalmology

10,976

$797K

1173
1073 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 63%

$73
Average prescription price

Avg: $88

JACQUELINE DAUHAJRE MD

Ophthalmology

10,010

$1.2M

1607
1369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

85%
prescriptions for brand name drugs

Avg: 63%

$120
Average prescription price

Avg: $88

CHARLES NILES M.D.

Ophthalmology

9,432

$609K

1231
1154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

64%
prescriptions for brand name drugs

Avg: 63%

$65
Average prescription price

Avg: $88

GREGORY HARMON MD

Ophthalmology

8,915

$1.06M

1086
1023 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

75%
prescriptions for brand name drugs

Avg: 63%

$119
Average prescription price

Avg: $88

ADAM LISH MD

Ophthalmology

8,224

$606K

928
857 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 63%

$74
Average prescription price

Avg: $88

JOHN KIM MD

Ophthalmology

8,141

$757K

1083
944 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

74%
prescriptions for brand name drugs

Avg: 63%

$93
Average prescription price

Avg: $88

RICHARD DANKNER M.D.

Ophthalmology

8,087

$658K

1141
1048 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

67%
prescriptions for brand name drugs

Avg: 63%

$81
Average prescription price

Avg: $88

STANLEY BYKOV MD

Ophthalmology

7,697

$759K

1017
965 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

87%
prescriptions for brand name drugs

Avg: 63%

$99
Average prescription price

Avg: $88

DAVID PINHAS M.D.

Ophthalmology

7,678

$535K

1100
1042 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 63%

$70
Average prescription price

Avg: $88

DANIEL LAROCHE M.D.

Ophthalmology

7,573

$466K

791
723 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

55%
prescriptions for brand name drugs

Avg: 63%

$62
Average prescription price

Avg: $88

MITSUGU SHIMMYO M.D.

Ophthalmology

7,227

$1.03M

606
556 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

82%
prescriptions for brand name drugs

Avg: 63%

$143
Average prescription price

Avg: $88

FIONA PATHAY MD

Ophthalmology

7,174

$703K

1131
975 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

79%
prescriptions for brand name drugs

Avg: 63%

$98
Average prescription price

Avg: $88

RAPHAEL VAZQUEZ M.D.

Ophthalmology

7,027

$1.09M

748
682 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

85%
prescriptions for brand name drugs

Avg: 63%

$155
Average prescription price

Avg: $88

REGINA SMOLYAK MD

Ophthalmology

6,642

$615K

809
771 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

81%
prescriptions for brand name drugs

Avg: 63%

$93
Average prescription price

Avg: $88

HARRY KOSTER MD

Ophthalmology

6,624

$588K

1277
1143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 63%

$89
Average prescription price

Avg: $88

RAYMOND REICH MD

Ophthalmology

6,529

$519K

1025
981 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 63%

$80
Average prescription price

Avg: $88

RAMIN MOSTAFAVI M.D.

Ophthalmology

6,224

$393K

1185
1047 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

55%
prescriptions for brand name drugs

Avg: 63%

$63
Average prescription price

Avg: $88

AMARJIT ATWAL MD

Ophthalmology

6,040

$594K

1278
1130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

76%
prescriptions for brand name drugs

Avg: 63%

$98
Average prescription price

Avg: $88

BINGJING ROBERTS M.D.

Ophthalmology

5,941

$902K

780
690 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

94%
prescriptions for brand name drugs

Avg: 63%

$152
Average prescription price

Avg: $88

JOSEPH ZELEFSKY MD

Ophthalmology

5,887

$473K

566
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

75%
prescriptions for brand name drugs

Avg: 63%

$80
Average prescription price

Avg: $88

ALAN JORDAN M.D.

Ophthalmology

5,858

$464K

728
661 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 63%

$79
Average prescription price

Avg: $88

STEVE PARK MD

Ophthalmology

5,858

$373K

1154
1088 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

19%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

55%
prescriptions for brand name drugs

Avg: 63%

$64
Average prescription price

Avg: $88

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank